Bacterial biofilms: the challenge of chronic infections and therapeutic failures

The treatment of chronic bacterial infectious diseases systematically encounters the resilience of biofilms. These microbial communities, protected by a dense matrix of extracellular polymeric substances (EPS), transform a common infection into a state refractory to eradication. The biofilm acts as a physicochemical and immunological barrier, limiting antibiotic penetration and isolating bacteria from the host's immune system. This clinical context requires a precise understanding of biofilm dynamics to restore the efficacy of antibacterial protocols.

This systematic review aims to detail the biofilm life cycle — from reversible adhesion to final dispersion — in order to identify specific intervention strategies at each stage. The authors focus particularly on the use of liposomes as targeted delivery vectors. The study tests the hypothesis that optimizing the physicochemical properties of liposomes (surface charge, PEG modification, cholesterol content) and their responsiveness to the acidic (pH 5 to 7) or oxidative (ROS) microenvironment allows for crossing the EPS barrier. The challenge is to target dormant bacteria at the core of the structure to prevent recurrent infections related to infected implants and colonized tissues.

Synthesis methodology

This narrative review synthesizes current data on the structural dynamics of bacterial biofilms and emerging therapeutic strategies. The analysis is based on a systemic decomposition of the biofilm life cycle and its biochemical microenvironment.

• Study design: Technical and taxonomic literature review of biofilm formation mechanisms and delivery vectors (liposomes).
• Life cycle modeling: The study categorizes formation into 5 distinct stages: reversible adhesion, irreversible adhesion, microcolony formation (maturation 1), complete maturation (maturation 2), and dispersion.
• Structural and environmental analysis: The authors detail a three-layer architecture (internal regulatory, basal microbial, and external) and characterize the infectious microenvironment according to precise parameters: acidic pH (5 to 7), glutathione concentrations (0.1 to 10 mM), hydrogen peroxide levels (H₂O₂ ~100 μM), lactate accumulation, and divalent ion gradients (Ca²⁺/Mg²⁺).
• Evaluated intervention strategies: The review analyzes interference protocols including Quorum Sensing inhibition (AHL molecules), physical penetration (ultrasound, PDT/PTT therapies) and the use of glycomimetic liposomes targeting lectins (LecA/LecB).
• Microbiological focus: A specific section is dedicated to Staphylococcus aureus (MRSA), evaluating the efficacy of curcumin-loaded cationic liposomes (C-LS/Cur) and the use of cholesterol derivatives (DC-Chol) or glycosylated lipids (GL4).

Mapping the biofilm microenvironment

This systematic review compiles data characterizing the specific environment of biofilm-infected tissues. The authors report biochemical parameters distinct from healthy tissues, creating both physical and chemical barriers to conventional therapies.

The structure is described as a three-dimensional complex organized into three distinct layers:

• Outer layer: High metabolic activity, facilitated access to nutrients.
• Microbial basal layer: Intermediate proliferation zone.
• Internal regulatory layer: Dormant bacteria (persister cells), deprived of nutrients, showing reduced drug sensitivity.

Specific strategies against S. aureus and MRSA

The review synthesises several approaches using liposomes as targeted vectors, notably to overcome the resistance of methicillin-resistant Staphylococcus aureus (MRSA). The compiled data highlight the importance of surface charge for biofilm penetration.

The authors report the following observations:

• Moxifloxacin Optimization: Antimicrobial efficacy is modulated by cholesterol content, liposomal concentration, and PEG surface modification.
• Electrostatic targeting (C-LS/Cur): The use of cationic liposomes loaded with curcumin allows for specific binding to the bacterial surfaces of S. aureus (negatively charged), increasing the local accumulation of the active ingredient.
• Membrane modifications: The integration of cationic cholesterol derivatives (DC-Chol) and glycosylated lipids (GL4) is identified as a lever to improve the liposome-bacteria interaction.

The synthesis highlights that the accumulation of divalent cations (Ca²⁺, Mg²⁺) stabilizes the extracellular polymeric substances (EPS) matrix by cross-linking polysaccharides and extracellular DNA (eDNA), thereby strengthening the structural integrity of the biofilm against debridement agents.

Analysis of intervention strategies on the biofilm cycle

The study details the biofilm cycle in five distinct stages, highlighting that the transition from reversible to irreversible adhesion constitutes the critical window for intervention. For the clinician, the results demonstrate that therapeutic efficacy depends not only on bactericidal activity, but on the ability to disrupt environmental sensing mechanisms (Quorum Sensing). The use of charged liposomes or glycomimetics allows for bypassing the initial attachment of bacteria to solid surfaces, thereby preventing the formation of the extracellular polymeric substance (EPS) matrix.

A crucial point revealed by this analysis is the structural heterogeneity of the mature biofilm. Bacteria in the outer layer, metabolically active, are more accessible, while deep-seated bacteria remain dormant and highly resistant. The study shows that liposomal vectors capable of responding to the characteristics of the infectious microenvironment (pH, enzymes, or redox state) offer a solution to penetrate this physical barrier and reach persistent cells. This approach overcomes the limitations of conventional antibiotics, which often struggle to diffuse through the three-dimensional complex of EPS.

However, the limitations of these strategies lie in the complexity of matrix stabilization by ionic gradients and the need for physical penetration that is sometimes required (ultrasound or photodynamic therapies). Although promising, these smart release modalities must still be optimized for standardized clinical application in the face of the resilience of mature biofilms.

Synthesis of biofilm mechanisms

This review defines biofilm as a structured three-dimensional complex in five stages of development, protected by a matrix of extracellular polymeric substances (EPS) acting as a physicochemical and immune barrier. The trilaminar architecture isolates dormant bacteria deep within, drastically reducing their metabolic activity and sensitivity to conventional treatments, which explains the persistence of chronic infections.

In concrete terms, for the practitioner:

• Anticipate recurrence: Apparent clinical success can mask persistent bacteria within the inner layer of the biofilm; rigorous physical debridement remains essential to break this protective structure that antibiotics alone cannot penetrate.
• Intervene early: The most effective therapeutic lever consists in blocking the transition from reversible adhesion to irreversible adhesion, before the colony secretes its complex protective matrix.
• Adapt your arsenal: Faced with a mature biofilm, prioritize combined approaches (physical + chemical) or the use of vectors such as loaded liposomes to target the specific microenvironment (acidic pH, ionic gradients) of deep infectious sites.

Technical lexicon for the study of bacterial biofilm

Extracellular Polymeric Substances (EPS): A complex three-dimensional matrix composed of exopolysaccharides, proteins, lipids, and extracellular DNA. It encapsulates bacteria, ensures structural cohesion, and acts as a physicochemical barrier against antibiotics and the immune system.

Quorum Sensing: Intercellular signaling mechanism allowing bacteria to perceive their population density and environmental stimuli to regulate the expression of genes related to virulence, metabolism, and matrix formation.

Irreversible Adhesion: Colonization stage where, after initial reversible contact, the massive secretion of adhesins permanently stabilizes the bond between the bacteria and the solid surface, marking the end of the planktonic state.

Dormant Bacteria: Micro-organisms located in the deep and regulatory layers of the biofilm. Their slowed metabolism and nutrient deprivation make them particularly resistant to antimicrobial agents that usually target actively dividing cells.

Charged Liposomes: Lipid vectors whose surface modification allows the use of electrostatic forces to target bacterial membranes, interfere with initial adhesion, or promote the penetration of active ingredients through the EPS.

Biofilm Dispersion: The final phase of the dynamic cycle where peripheral bacteria return to a planktonic state following the disintegration of the EPS matrix, leading to the dissemination of the infection to new biological sites.

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims all responsibility regarding the use of this information. This document is not intended for patients or the general public.